BRPI0520593A2 - uso de betaìna, dimetilglicina ou sais internos de betaìna nas formas anidra e hidratada, e, composição nutricional - Google Patents

uso de betaìna, dimetilglicina ou sais internos de betaìna nas formas anidra e hidratada, e, composição nutricional

Info

Publication number
BRPI0520593A2
BRPI0520593A2 BRPI0520593-0A BRPI0520593A BRPI0520593A2 BR PI0520593 A2 BRPI0520593 A2 BR PI0520593A2 BR PI0520593 A BRPI0520593 A BR PI0520593A BR PI0520593 A2 BRPI0520593 A2 BR PI0520593A2
Authority
BR
Brazil
Prior art keywords
betaine
nutritional composition
dimethylglycine
hydrated forms
anhydrous
Prior art date
Application number
BRPI0520593-0A
Other languages
English (en)
Inventor
Johannes Adrianus Cornelis Peters
Marchel Gorselink
Klaske Van Norren
Robert Johan Joseph Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0520593A2 publication Critical patent/BRPI0520593A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Seasonings (AREA)

Abstract

USO DE BETAìNA, DIMETILGLICINA OU SAIS INTERNOS DE BETAINA NAS FORMAS ANIDRA E HIDRATADA, E, COMPOSIçãO NUTRICIONAL. A invenção refere-se ao tratamento ou à redução da incidência de desgaste muscular em humanos e a uma composição nutricional completa em pacientes que sofrem de desgaste muscular, compreendendo betaína e preferivelmente coenzima Q10.
BRPI0520593-0A 2005-10-07 2005-10-07 uso de betaìna, dimetilglicina ou sais internos de betaìna nas formas anidra e hidratada, e, composição nutricional BRPI0520593A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2005/050010 WO2007043857A1 (en) 2005-10-07 2005-10-07 Nutrition comprising betaine against muscle wasting

Publications (1)

Publication Number Publication Date
BRPI0520593A2 true BRPI0520593A2 (pt) 2009-10-06

Family

ID=36499171

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520593-0A BRPI0520593A2 (pt) 2005-10-07 2005-10-07 uso de betaìna, dimetilglicina ou sais internos de betaìna nas formas anidra e hidratada, e, composição nutricional

Country Status (8)

Country Link
US (1) US20080267941A1 (pt)
EP (1) EP1931223B1 (pt)
CN (1) CN101277617A (pt)
AT (1) ATE424120T1 (pt)
BR (1) BRPI0520593A2 (pt)
DE (1) DE602005013133D1 (pt)
ES (1) ES2323143T3 (pt)
WO (1) WO2007043857A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3952857A4 (en) 2019-04-10 2023-01-04 The Regents of the University of Colorado, a Body Corporate COMPOSITIONS AND METHODS FOR THE TREATMENT OF HOMOCYSTINURIA AND OTHER INFLAMMATORY DISEASES
CN110585266A (zh) * 2019-09-18 2019-12-20 广东润和生物科技有限公司 紫苏籽油与辅酶q10组合物的应用
WO2022181936A1 (ko) * 2021-02-26 2022-09-01 이엑스헬스케어 주식회사 피부 유래 엑소좀을 통해 근손실 억제 또는 근생성 촉진 효과를 나타내는 조성물
CN115868634A (zh) * 2021-09-28 2023-03-31 深圳芙莱特营养与健康有限公司 一种增强耐力的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US7740878B2 (en) * 2001-10-22 2010-06-22 Danisco A/S Use of betaine to enhance exercise performance
US20040156882A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and composition for feeding mammals
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology

Also Published As

Publication number Publication date
EP1931223B1 (en) 2009-03-04
ATE424120T1 (de) 2009-03-15
ES2323143T3 (es) 2009-07-07
WO2007043857A1 (en) 2007-04-19
EP1931223A1 (en) 2008-06-18
CN101277617A (zh) 2008-10-01
US20080267941A1 (en) 2008-10-30
DE602005013133D1 (de) 2009-04-16

Similar Documents

Publication Publication Date Title
UY31497A1 (es) Nuevos compuestos para el tratamiento de trastornos del snc
CY1122128T1 (el) Θεραπεια ενζυμικης αντικαταστασης με κλιμακωση δοσης για αντιμετωπιση ανεπαρκειας σε οξινη σφιγγομυελιναση
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
SI1971366T1 (sl) Humana protitelesa anti-il-23, sestavki, postopki in uporabe
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
EA200900044A1 (ru) Замещенные производные 1,3-дифенилпропана, получение и их применение
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
BRPI0410503B8 (pt) composição tópica e uso da composição
ATE534378T1 (de) Titrierung von tapentadol
BR0312165A (pt) Utilização da taurina para o tratamento da alopecia
WO2009144093A8 (en) Hydroxytyrosol benefits mitochondria
ATE453642T1 (de) Substituierte phenylaminopyrimidine
BRPI0716985A2 (pt) Composição nutricional, uso da mesma, e, suplemento nutricional para o tratamento de pacientes que sofrem de alergias a alimentos
DK1680128T3 (da) Myo-inositolhexaphosphat til topisk anvendelse
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
UA104714C2 (ru) Выделенный полинуклеотид brachyspira hyodysenteriae, кодирующий полипептид, и его применение
ECSP077423A (es) Coadministración de tigeciclina y digoxin
BRPI0520593A2 (pt) uso de betaìna, dimetilglicina ou sais internos de betaìna nas formas anidra e hidratada, e, composição nutricional
EA201070704A1 (ru) Устройство для снабжения зубной пастой путем нанесения ее на зубную щетку
BRPI0918408A2 (pt) composição farmacêutica de dose oral unitária simples compreendendo levodopa, carbidopa e entacapona ou sais das mesmas
ATE524488T1 (de) Lysobactinamide
CY1108501T1 (el) Συνθεση δια την προληψη και θεραπευτικη αγωγη ασθενειων κρυολογηματος
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO PARECER DA PROCURADORIA NO 074/93, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO A MESMA CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/205 (2006.01), A23L 2/52 (2006.01), A23L 3

B11T Dismissal of application maintained [chapter 11.20 patent gazette]